With our long history of advancing kidney care, DaVita Clinical Research® brings exceptional depth of knowledge and clinical expertise in renal research and clinical trial operations for Phase II-IV trials.
With access to 1/3 of the total US end-stage renal disease (ESRD) patient population, we can access our dense patient-level data to guide the design of your protocol, identify sites, and quickly enroll trial subjects. Our team has a 25-year track record of employing a resourceful approach that will enable you to make confident decisions and meet your study timelines.
Our access to patients and our long-standing relationships with investigator physicians allow us to get study sites up and running efficiently and effectively using data-driven metrics to select the best sites for clinical studies.
No other clinical research organization has deeper experience in conducting renal trials. DaVita Clinical® Research has had direct engagement on every end-stage renal drug that has received FDA approval in the past 15 years.
For more details about our Late Stage Clinical Research services, download our brochure.